This page contains a Flash digital edition of a book.
NEWS NEWS IN BRIEF


NUMARk BECoMES


PHARMASSISt GoLD PARtNER


PharmAssist Solutions has announced a partnership with Numark to provide the virtual chain’s members with access to innovative technology that gives compliance and control, driving efficiency and margin into purchasing decisions that have a real effect on the bottom line.


Numark’s Director of Commercial Operations, Raj Nutan, unveiled details of the relationship at Numark’s International Conference in Buenos Aires last month.


He said, “As part of our function as a head office to independent pharmacy, we need a range of partners that can provide our members with access to buying solutions that help them gain control of the supply end of their business. Our suite of offerings includes schemes from Teva and Actavis, our Numerics generics scheme and now


a technology-led system ― PharmAssist Elite. Whatever type of pharmacy or pharmacies you run, and however you prefer to manage your buying, we have a solution for you.”


PharmAssist Solutions offers a set of software solutions to the independent pharmacy market that drives compliance and control. Its retail offer ranges from full group warehousing and retail control solutions down to individual user compliance packages.


PharmAssist Elite manages the order function for single outlet or small groups of pharmacies. It encompasses Cascade- a sophisticated programme that always orders the lowest priced molecule from the group of suppliers the pharmacy selects. It deals with out of stocks and code mapping errors in real time via a seamless link to RX Systems’ PMRs (NumarkAssist, ProScript and ProScript Link).


As the system assesses prices over a large range, it leads to an improvement in pharmacy profitability and it works for generics, parallel imports, surgical and OTC products.


42 - SCOTTISH PHARMACIST


Local researchers explore medication errors


Health researchers from Aberdeen have secured significant funding for an innovative project to explore medication errors and adverse drug reactions in the Middle East.


Professor Derek Stewart from Robert Gordon University’s (RGU) School of Pharmacy and Life Sciences, and principal researcher in RGU’s Institute for Health and Wellbeing Research (IHWR), leads an experienced research team which aims to help Saudi Arabia enhance its healthcare provision.


His team has recently been awarded a research grant of £130,000 from the Kingdom of Saudi Arabia’s National Science, Technology and Innovation Plan.


The project involves researchers from RGU, the University of Aberdeen and Queen’s University Belfast working with a team from Saudi Arabia led by Dr Mansour Tobaiqy.


The recent award follows £350,000 in funding last year from the Qatar National Research Fund (QNRF) to identify what causes medication errors


and the organisation’s subsequent reporting structures.


Professor Stewart has developed strong links in the Middle East and is delighted to build on the university’s existing portfolio of collaborative working in the region.


He says, “We are very proud to have secured a significant funding award from Saudi Arabia’s National Science, Technology and Innovation Plan. A lot of work went in to the application process and now we’re looking forward to starting our research.


“This is an exciting venture which will combine expertise in the UK and the Middle East to improve patient safety and appropriate uses of medicines.”


Professor Cherry Wainwright, Director of RGU’s Institute for Health & Wellbeing Research said: “This funding


Professor Derek


Stewart, School of Pharmacy, RGU


award not only reflects Professor Stewarts’ international reputation in the field of medication errors, but also reflects that this is a global problem that needs to be tackled.”


Alphega hold 7th European Convention


Alphega Pharmacy recently concluded its seventh European Convention today at the Grimaldi Forum in Monaco, which attracted more than more than 1,000 delegates from across eight countries.


Under the event’s theme of ‘Stay independent, lead the future’, a series of seminars and workshops reiterated how independent pharmacists can lead the future with pharmacy at the heart of healthcare.


The Alphega Pharmacy European Convention is the independent pharmacy network’s first international event following the creation of Walgreens Boots Alliance in December 2014.


Ornella Barra, Executive Vice President, President and Chief Executive of Global Wholesale & International Retail of Walgreens Boots Alliance, delivered the closing speech at the event and reaffirmed the new Company’s commitment to independent pharmacy.


“Our commitment to the pharmacy profession and to independent pharmacy has never been stronger. As the first global, pharmacy-led health and wellbeing enterprise, our combined strength, scale and expertise will bring additional benefits to


independent pharmacists and enable Alphega Pharmacy to continue to flourish. Pharmacy remains a key priority of Walgreens Boots Alliance and I look forward to seizing new exciting opportunities together,” she stated.


The Convention celebrated recent achievements, and also looked to future expansion of the brand in other markets. Highlights included: • Germany: The rebranding of vivesco to Alphega, which started in July 2014


• The Netherlands: The completion of the rebranding of Alphega pharmacies • France: The launch of new services, including a sore throat screening service • UK: More than half the members with their own page on the consumer website • Spain: The launch of a Dependent Patients Carer Guide to help support carers of dependent patients • Turkey: An initial pilot in Istanbul customising Alphega Pharmacy services for the local market


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60